Allosteric and ATP-competitive kinase inhibitors of mTOR for cancer treatment

被引：65
|
作者：
Garcia-Echeverria, Carlos [1 ]
机构：
[1] Sanofi Aventis, Oncol Drug Discovery, F-94400 Vitry Sur Seine, France
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 15期
关键词：
Kinase inhibitors; mTOR; Anticancer agents; MAMMALIAN TARGET; RAPAMYCIN; PATHWAY; DISCOVERY; TYROSINE; COMPLEX; POTENT; PI3K;
D O I：
10.1016/j.bmcl.2010.05.099
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Over the past few years a number of components of the PI3K/mTOR pathway have been the subject of intense drug discovery activities both in pharmaceutical companies and in academia. This review article summarizes progress made in the identification and development of allosteric and ATP-competitive kinase inhibitors of mTOR and their potential therapeutic use in oncology. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：4308 / 4312
页数：5
相关论文
共 50 条
  • [1] ATP-Competitive Inhibitors of mTOR: An Update
    Schenone, S.
    Brullo, C.
    Musumeci, F.
    Radi, M.
    Botta, M.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (20) : 2995 - 3014
  • [2] Latent allosteric control of protein interactions by ATP-competitive kinase inhibitors
    Vaisar, David
    Ahn, Natalie G.
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2024, 89
  • [3] Recent progress in the development of ATP-Competitive and allosteric akt kinase inhibitors
    Lindsley, Craig W.
    Barnett, Stanley F.
    Yaroschak, Melissa
    Bilodeau, Mark T.
    Layton, Mark E.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (14) : 1349 - 1363
  • [4] Inhibitors in AKTion: ATP-competitive vs allosteric
    Lazaro, Glorianne
    Kostaras, Eleftherios
    Vivanco, Igor
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2020, 48 (03) : 933 - 943
  • [5] Marine-Derived Natural Products as ATP-Competitive mTOR Kinase Inhibitors for Cancer Therapeutics
    Parate, Shraddha
    Kumar, Vikas
    Lee, Gihwan
    Rampogu, Shailima
    Hong, Jong Chan
    Lee, Keun Woo
    PHARMACEUTICALS, 2021, 14 (03)
  • [6] Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells
    Benjamin Blaser
    Laurent Waselle
    Anne Dormond-Meuwly
    Marc Dufour
    Didier Roulin
    Nicolas Demartines
    Olivier Dormond
    BMC Cancer, 12
  • [7] Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells
    Blaser, Benjamin
    Waselle, Laurent
    Dormond-Meuwly, Anne
    Dufour, Marc
    Roulin, Didier
    Demartines, Nicolas
    Dormond, Olivier
    BMC CANCER, 2012, 12
  • [8] Furthering the design and the discovery of small molecule ATP-competitive mTOR inhibitors as an effective cancer treatment
    Lv, Xiaoqing
    Ma, Xiaodong
    Hu, Yongzhou
    EXPERT OPINION ON DRUG DISCOVERY, 2013, 8 (08) : 991 - 1012
  • [9] ATP-competitive inhibitors of mTOR: new perspectives in the treatment of renal cell carcinoma
    Roulin, Didier
    Demartines, Nicolas
    Dormond, Olivier
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2011, 39 : 492 - 494
  • [10] Characterization of both allosteric and ATP-competitive kinase inhibitors with TR-FRET binding assays
    Fakhoury, Stephen A.
    Lebakken, Connie
    Marks, Bryan
    Wolken, Jill K.
    Riddle, Steven M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
12345